All News InnoCan Pharma Corporation

Equities

INNO

CA45783P1027

Market Closed - Canadian Securities Exchange Other stock markets 20:47:28 26/04/2024 BST			5-day change	1st Jan Change
0.28 ^CAD	+1.82%		+3.70%	-9.68%

04-01	InnoCan Pharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
03-25	Innocan Pharma Corporation Announces the Signing of an Agreement with the Hebrew University	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain	04-22	AQ
InnoCan Pharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	04-01	CI
Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M	04-01	AQ
Innocan Pharma Corporation Announces the Signing of an Agreement with the Hebrew University	03-25	CI
InnoCan Pharma "Paves Its Way" to LPT-CBD Chemistry, Manufacturing and Controls (CMC), "Key Milestones" for FDA Approval	03-25	MT
Innocan Pharma paves its way to LPT-CBD Chemistry, Manufacturing and Controls (CMC), key milestones for FDA approval.	03-25	AQ
Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of Approximately C$2 Million	03-15	AQ
InnoCan Pharma Corporation announced that it has received CAD 1.98821 million in funding	03-13	CI
Innocan Pharma Corporation Announces Tissue Distribution Study of LPT-CBD to the Brain	03-05	CI
Innocan Pharma's LPT-CBD Has the Potential to Support a new Therapeutic Venue for Neurological Disorders According to Recent Study	03-05	AQ
InnoCan Pharma Corporation announced that it expects to receive CAD 3 million in funding	03-04	CI
InnoCan Pharma Corporation Announces Study Findings That Lpt-Cbd Maintain Its Prolonged Release in Rabbits	02-26	CI
Innocan Pharma Announces Study Findings that LPT-CBD maintains its prolonged release in Rabbits	02-26	AQ
Innocan Pharma to participate in the White Label World Expo on February 27-28th, 2024	02-20	AQ
Innocan Provides Corporate Update & Preliminary Q4 and Fiscal Year 2023 Financial Highlights	02-13	AQ
Innocan Pharma to provide a corporate update via Zoom livestream on February 12, 2024, at 4:00pm EST	02-05	AQ
Innocan Pharma Announces Expert Team for LPT CBD Application to United States Food and Drug Administration	12-12	AQ
InnoCan Pharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-29	CI
InnoCan Pharma Brief: Says "Surge" in revenue Primarily attributable to "Robust" sales performance of Subsidiary, B.I. Sky Global Ltd.	11-29	MT
InnoCan Pharma Brief: Reporting US$4.083 Million In Revenues for Q3 2023 Vs US$749,000 for Q3 2022, representing an increase of 445%	11-29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News InnoCan Pharma Corporation

Equities

INNO

CA45783P1027

All News

Filters